DAF-FM DA
DAF-FM DA structure
|
Common Name | DAF-FM DA | ||
|---|---|---|---|---|
| CAS Number | 254109-22-3 | Molecular Weight | 496.41600 | |
| Density | 1.56±0.1 g/cm3(Predicted) | Boiling Point | 695.7±55.0 °C(Predicted) | |
| Molecular Formula | C25H18F2N2O7 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of DAF-FM DADAF-FM DA is a reagent to detect and quantify low concentrations of nitric oxide (NO); DAF-FM fluorescence can be detected by any instrument that can detect fluorescein, including flow cytometers, microscopes, fluorescent microplate readers and fluorometers. |
| Name | [6'-acetyloxy-4-amino-2',7'-difluoro-5-(methylamino)-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl] acetate |
|---|---|
| Synonym | More Synonyms |
| Description | DAF-FM DA is a reagent to detect and quantify low concentrations of nitric oxide (NO); DAF-FM fluorescence can be detected by any instrument that can detect fluorescein, including flow cytometers, microscopes, fluorescent microplate readers and fluorometers. |
|---|---|
| Related Catalog |
| Density | 1.56±0.1 g/cm3(Predicted) |
|---|---|
| Boiling Point | 695.7±55.0 °C(Predicted) |
| Molecular Formula | C25H18F2N2O7 |
| Molecular Weight | 496.41600 |
| Exact Mass | 496.10800 |
| PSA | 126.18000 |
| LogP | 4.66150 |
| RIDADR | NONH for all modes of transport |
|---|
|
Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.
Radiology 251(3) , 697-704, (2009) To determine whether a type of contrast medium (CM), iodixanol, modifies outer medullary descending vasa recta (DVR) vasoreactivity and nitric oxide (NO) production in isolated microperfused DVR.Anima... |
|
|
Propofol protects against the neurotoxicity of 1‑methyl‑4‑phenylpyridinium.
Mol. Med. Report. 13 , 309-14, (2015) Parkinson's disease (PD) is a progressive and degenerative disorder of the central nervous system, characterized by the loss of dopaminergic neurons and muscular rigidity. Treatment with propofol (2,6... |
|
|
Proinsulin C-peptide prevents impaired wound healing by activating angiogenesis in diabetes.
J. Invest. Dermatol. 135(1) , 269-78, (2014) Diabetes mellitus disrupts wound repair and leads to the development of chronic wounds, likely due to impaired angiogenesis. We previously demonstrated that human proinsulin C-peptide can protect agai... |
| DAF-FM DA |
| Diaminofluorescein-FM diacetate |
| 3-Amino-4-(N-methylamino)-2',7'-difluorofluorescein diacetate |